)
Pharmaceuticals firm Zydus Cadila today said it has received final approval from US health regulator to market Clonidine Hcl injections used in treating severe pain in cancer patients.
The approval from the US Food and Drug Administration (USFDA) is for Clonidine Hcl injections of strength 0.1mg/ml, 0.5mg/ml and 10mg/ml the company said in a filing to the BSE.
The injection is used in treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone.
The company has now 90 approvals and has so far filed 216 abbreviated new drug applications since the filing process began in 2003-04, it added.
Shares of the company closed 4.69 per cent higher at Rs 995.10 apiece on the BSE today.
